Cipher Pharmaceuticals Inc. (FRA:PHE)

Cipher Pharmaceuticals Statistics

Total Valuation

FRA:PHE has a market cap or net worth of EUR 231.79 million. The enterprise value is 236.05 million.

Market Cap	231.79M
Enterprise Value	236.05M

Important Dates

The next estimated earnings date is Thursday, March 19, 2026.

Earnings Date	Mar 19, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	25.37M
Shares Outstanding	n/a
Shares Change (YoY)	+4.82%
Shares Change (QoQ)	-2.11%
Owned by Insiders (%)	78.63%
Owned by Institutions (%)	1.51%
Float	5.42M

Valuation Ratios

The trailing PE ratio is 15.66.

PE Ratio	15.66
Forward PE	n/a
PS Ratio	5.43
PB Ratio	2.39
P/TBV Ratio	11.91
P/FCF Ratio	9.10
P/OCF Ratio	9.10
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.98, with an EV/FCF ratio of 9.27.

EV / Earnings	15.95
EV / Sales	5.50
EV / EBITDA	13.98
EV / EBIT	21.56
EV / FCF	9.27

Financial Position

The company has a current ratio of 1.30, with a Debt / Equity ratio of 0.12.

Current Ratio	1.30
Quick Ratio	0.91
Debt / Equity	0.12
Debt / EBITDA	0.68
Debt / FCF	0.45
Interest Coverage	7.98

Financial Efficiency

Return on equity (ROE) is 16.32% and return on invested capital (ROIC) is 5.98%.

Return on Equity (ROE)	16.32%
Return on Assets (ROA)	5.30%
Return on Invested Capital (ROIC)	5.98%
Return on Capital Employed (ROCE)	10.05%
Revenue Per Employee	8.53M
Profits Per Employee	2.96M
Employee Count	5
Asset Turnover	0.33
Inventory Turnover	2.15

Taxes

Income Tax	-6.53M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.58% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-5.58%
50-Day Moving Average	8.91
200-Day Moving Average	8.41
Relative Strength Index (RSI)	62.74
Average Volume (20 Days)	50

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:PHE had revenue of EUR 42.66 million and earned 14.80 million in profits. Earnings per share was 0.57.

Revenue	42.66M
Gross Profit	31.71M
Operating Income	10.89M
Pretax Income	8.26M
Net Income	14.80M
EBITDA	16.65M
EBIT	10.89M
Earnings Per Share (EPS)	0.57

Balance Sheet

The company has 7.18 million in cash and 11.41 million in debt, giving a net cash position of -4.24 million.

Cash & Cash Equivalents	7.18M
Total Debt	11.41M
Net Cash	-4.24M
Net Cash Per Share	n/a
Equity (Book Value)	97.11M
Book Value Per Share	3.83
Working Capital	5.31M

Cash Flow

In the last 12 months, operating cash flow was 25.47 million and capital expenditures -8,523, giving a free cash flow of 25.46 million.

Operating Cash Flow	25.47M
Capital Expenditures	-8,523
Free Cash Flow	25.46M
FCF Per Share	n/a

Margins

Gross margin is 74.32%, with operating and profit margins of 25.52% and 34.69%.

Gross Margin	74.32%
Operating Margin	25.52%
Pretax Margin	19.37%
Profit Margin	34.69%
EBITDA Margin	39.03%
EBIT Margin	25.52%
FCF Margin	59.68%

Dividends & Yields

FRA:PHE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.82%
Shareholder Yield	-4.82%
Earnings Yield	6.38%
FCF Yield	10.98%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:PHE has an Altman Z-Score of 6.03 and a Piotroski F-Score of 6.

Altman Z-Score	6.03
Piotroski F-Score	6